97608726 - TARGET HEALTH

Information

• Trademark
• 97608726

• Source

• Serial Number

  97608726

• International Classifications

  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  September 27, 2022
  2 years ago

• Transaction Date

  November 14, 2023
  a year ago

• Status Date

  November 14, 2023
  a year ago

• Location Date

  November 14, 2023
  a year ago

• Status Code

  602

• Current Location

  TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  FROMM, MARTHA L

• Attorney Docket Number

  4107.00043

  Attorney Name

  Kenneth I. Kohn

  Law Office Assigned Location Code

  L60

• Owners

  • Target Health LLC

Case File Statements

• DM0000: The mark consists of The mark consists of the words "Target Health" in black, above the word "Health" from the "e'' to the "h" is the upper half of a red and white target, centered on the target is the caduceus symbol in black and white.
• CC0000: The color(s) black, white and red is/are claimed as a feature of the mark.
• GS0351: Data processing; providing statistical information for business or commercial purposes; Business auditing services; Data processing services in the biostatistics field; Performing statistical analysis for business or commercial purposes; Manufacturer representatives in the field of pharmaceuticals; Development of business processes for the analysis and implementation of clinical trials dealing with pharmaceutical drug development
• GS0451: Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding food and drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical products
• GS0421: Providing online computer database for use in gathering and providing clinical trials data regarding medical and scientific research; Scientific research; Research in the medical and pharmaceutical fields; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs as it relates to medical and scientific research in the development of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development, namely, conducting clinical trials; consultation in the fields of pharmaceutical drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; Development of pharmaceutical product processes for others; Technical writing for others, namely, writing integrated clinical and statistical study reports and regulatory manuscripts related to medical and scientific research in the development of pharmaceutical drugs, as an integrated component; compiling patient records and patient data via a global computer information network for research purposes in the field of medical science and medical consultancy

Case File Event Statements

• 11/14/2023 - a year ago

  10 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 11/14/2023 - a year ago

  9 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 11/14/2023 - a year ago

  8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 7/31/2023 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/31/2023 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/31/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/11/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/15/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 10/14/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/30/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP